Most Recent Articles about AMGN
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data http://www.zacks.com/stock/news/431676/biotech-stock-roundup-amgen-gets-fda-nod-for-kanjinti-regeneron-presents-data?cid=CS-ZC-FT-431676 Jun 19, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Big Drugmakers That May Tread the M&A Path After Pfizer http://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer?cid=CS-ZC-FT-431504 Jun 19, 2019 - There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.
Top Analyst Reports for Broadcom, Amgen & NVIDIA http://www.zacks.com/research-daily/431127/top-analyst-reports-for-broadcom-amgen-nvidia?cid=CS-ZC-FT-431127 Jun 18, 2019 - Top Analyst Reports for Broadcom, Amgen & NVIDIA

Related Companies

Name Exchange Price Mkt Cap
GILD Gilead Sciences, Inc. NASDAQ $72.78 $94.35B
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)